Updates from The Motley Fool

Latest updates on Regeneron Pharmaceuticals from Fool.com.

Stock Performance

REGN vs. S&P 500 | 2 Year Performance
REGN 1-Day Stock Chart
REGN 5-Day Stock Chart
REGN 1-Month Stock Chart
REGN 3-Month Stock Chart
REGN 6-Month Stock Chart
REGN 1-Year Stock Chart
REGN 2-Year Stock Chart
REGN 5-Year Stock Chart
View Interactive REGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Regeneron Pharmaceuticals.
Current Price: $376.71
Prev Close: $391.30
Open: $388.63
Bid: $375.01
Ask: $377.79
Day's Range: $373.14 - $393.00
52wk Range: $348.96 - $605.93
Volume: 889,592
Avg Vol 967,334
Market Cap: $39.20B
P/E (ttm): 70.89
EPS (ttm): $5.52
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Regeneron Pharmaceuticals.
CAPS Rating 3 out of 5
379 Outperform
74 Underperform
CAPS All Stars
85 Outperform
18 Underperform

How do you think Regeneron Pharmaceuticals will perform against the market?

You pick for Regeneron Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Leonard S. Schleifer, CEO

98% Approve

Based on 124 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Regeneron Pharmaceuticals.

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers